Averill Master Fund, Ltd. is Director & 10% Owner at Benitec Biopharma Inc. (BNTC). They have made 1 open-market trade across 1 company since 2024, most recently 2024-11-20.
CIK 0001939329
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $787K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BNTC | 7,895,815 | $63.9M |
Shares reported on the most recent Form 4, priced at the 2024-11-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BNTC | BUY | 2024-11-19 | 2024-11-21 | $10.05 | $787K | -3.4% | +10.2% | +9.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.